Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Acta Pharmacologica Sinica (2)
Scientific Reports (1)
Nature Catalysis (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)

Subject Check one or more subjects to show results from those subjects only.

Chemistry
Rheumatology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Ming-kai Xu Clear advanced filters

Visible-light photocatalytic di- and hydro-carboxylation of unactivated alkenes with CO₂

The activation of CO₂ for catalytic carboxylation of alkenes is mainly limited to two-electron processes. Now, a visible-light photocatalytic single-electron transfer reduction of CO₂ is reported leading to the key intermediate CO₂^•−, which allows carboxylation of unactivated aliphatic alkenes.

Lei Song
Wei Wang
Da-Gang Yu
Research15 Sept 2022
Nature Catalysis

Volume: 5, P: 832-838
Discovery of novel PDE10 inhibitors by a robust homogeneous screening assay

Qun-yi Li
Ming-kai Xu
Ming-wei Wang
Research22 Apr 2013
Acta Pharmacologica Sinica

Volume: 34, P: 1116-1120
The MRI-based vertebral bone quality score is a predictor of pedicle screw loosening following instrumented posterior lumbar fusion

Yung-Hsueh Hu
Jian-Hong Chou
Chi-Chien Niu
ResearchOpen Access11 Jan 2025
Scientific Reports

Volume: 15, P: 1-9
An engineered IL-21 variant is a potent antitumor candidate for antitumor immunotherapy

Hui Wu
Ya-ping Cheng
Yan-ling Wu
Research17 Oct 2025
Acta Pharmacologica Sinica

P: 1-9